{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:34:51Z","timestamp":1757619291617,"version":"3.44.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Research and innovation fund of the First Affiliated Hospital of Harbin Medical University","award":["2024M22"],"award-info":[{"award-number":["2024M22"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"DOI":"10.1186\/s12880-025-01829-4","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T14:23:57Z","timestamp":1753107837000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The value of habitat analysis based on 18F-PSMA-1007 PET\/CT images for prostate cancer risk grading"],"prefix":"10.1186","volume":"25","author":[{"given":"Yang","family":"Wang","sequence":"first","affiliation":[]},{"given":"Hongyue","family":"Zhao","sequence":"additional","affiliation":[]},{"given":"Zhehao","family":"Lyu","sequence":"additional","affiliation":[]},{"given":"Linhan","family":"Zhang","sequence":"additional","affiliation":[]},{"given":"Wei","family":"Han","sequence":"additional","affiliation":[]},{"given":"Zeyu","family":"Wang","sequence":"additional","affiliation":[]},{"given":"Jiafu","family":"Wang","sequence":"additional","affiliation":[]},{"given":"Xinyue","family":"Zhang","sequence":"additional","affiliation":[]},{"given":"Shibo","family":"Guo","sequence":"additional","affiliation":[]},{"given":"Peng","family":"Fu","sequence":"additional","affiliation":[]},{"given":"Changjiu","family":"Zhao","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,7,21]]},"reference":[{"issue":"3","key":"1829_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"Cancer J Clin"},{"key":"1829_CR2","doi-asserted-by":"crossref","unstructured":"De Silva F, Alcorn J. A Tale of two cancers: A current concise overview of breast and prostate Cancer. Cancers 2022, 14(12).","DOI":"10.3390\/cancers14122954"},{"issue":"1","key":"1829_CR3","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.eururo.2019.08.005","volume":"77","author":"MB Culp","year":"2020","unstructured":"Culp MB, Soerjomataram I, Efstathiou JA, Bray F, Jemal A. Recent global patterns in prostate Cancer incidence and mortality rates. Eur Urol. 2020;77(1):38\u201352.","journal-title":"Eur Urol"},{"issue":"2","key":"1829_CR4","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s00259-021-05430-z","volume":"49","author":"EL Solari","year":"2021","unstructured":"Solari EL, Gafita A, Schachoff S, Bogdanovi\u0107 B, Villagr\u00e1n Asiares A, Amiel T, Hui W, Rauscher I, Visvikis D, Maurer T, et al. The added value of PSMA PET\/MR radiomics for prostate cancer staging. Eur J Nucl Med Mol Imaging. 2021;49(2):527\u201338.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1829_CR5","doi-asserted-by":"crossref","unstructured":"Schatten H. Brief Overview of Prostate Cancer Statistics, Grading, Diagnosis and Treatment Strategies. In: Cell & Molecular Biology of Prostate Cancer. 2018: 1\u201314.","DOI":"10.1007\/978-3-319-95693-0_1"},{"issue":"4","key":"1829_CR6","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nrurol.2016.26","volume":"13","author":"T Maurer","year":"2016","unstructured":"Maurer T, Eiber M, Schwaiger M, Gschwend JE. Current use of PSMA\u2013PET in prostate cancer management. Nat Reviews Urol. 2016;13(4):226\u201335.","journal-title":"Nat Reviews Urol"},{"issue":"4","key":"1829_CR7","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/pros.24294","volume":"82","author":"PJ Vlachostergios","year":"2022","unstructured":"Vlachostergios PJ, Niaz MJ, Thomas C, Christos PJ, Osborne JR, Margolis DJA, Khani F, Bander NH, Scherr DS, Tagawa ST. Pilot study of the diagnostic utility of 89Zr-df\u2010IAB2M and 68Ga\u2010PSMA\u201011 PET imaging and multiparametric MRI in localized prostate cancer. Prostate. 2022;82(4):483\u201392.","journal-title":"Prostate"},{"issue":"2","key":"1829_CR8","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.ucl.2014.01.011","volume":"41","author":"MA Bjurlin","year":"2014","unstructured":"Bjurlin MA, Wysock JS, Taneja SS. Optimization of prostate biopsy. Urol Clin North Am. 2014;41(2):299\u2013313.","journal-title":"Urol Clin North Am"},{"issue":"3","key":"1829_CR9","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/1754-9485.13284","volume":"66","author":"F Paterson","year":"2021","unstructured":"Paterson F, Nottage M, Kitchener M, Jarvis M, Reid J, Oakden-Rayner L. Assessing the accuracy of 68Ga\u2010PSMA PET\/CT compared with MRI in the initial diagnosis of prostate malignancy: A cohort analysis of 114 consecutive patients. J Med Imaging Radiat Oncol. 2021;66(3):319\u201323.","journal-title":"J Med Imaging Radiat Oncol"},{"issue":"6","key":"1829_CR10","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s00259-017-3631-6","volume":"44","author":"C Uprimny","year":"2017","unstructured":"Uprimny C, Kroiss AS, Decristoforo C, Fritz J, von Guggenberg E, Kendler D, Scarpa L, di Santo G, Roig LG, Maffey-Steffan J, et al. Ga-PSMA-11 PET\/CT in primary staging of prostate cancer: PSA and Gleason score predict the intensity of tracer accumulation in the primary tumour. Eur J Nucl Med Mol Imaging. 2017;44(6):68.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1829_CR11","doi-asserted-by":"crossref","unstructured":"Cho H-h, Kim H, Nam SY, Lee JE, Han B-K, Ko EY, Choi JS, Park H, Ko ES. Measurement of perfusion heterogeneity within tumor habitats on magnetic resonance imaging and its association with prognosis in breast Cancer patients. Cancers 2022, 14(8).","DOI":"10.3390\/cancers14081858"},{"key":"1829_CR12","doi-asserted-by":"crossref","unstructured":"Mu W, Liang Y, Hall LO, Tan Y, Balagurunathan Y, Wenham R, Wu N, Tian J, Gillies RJ. 18F-FDG PET\/CT habitat radiomics predicts outcome of patients with cervical Cancer treated with chemoradiotherapy. Radiology: Artif Intell 2020, 2(6).","DOI":"10.1148\/ryai.2020190218"},{"key":"1829_CR13","doi-asserted-by":"crossref","unstructured":"Bailo M, Pecco N, Callea M, Scifo P, Gagliardi F, Presotto L, Bettinardi V, Fallanca F, Mapelli P, Gianolli L et al. Decoding the heterogeneity of malignant gliomas by PET and MRI for Spatial habitat analysis of hypoxia, perfusion, and diffusion imaging: A preliminary study. Front NeuroSci 2022, 16.","DOI":"10.3389\/fnins.2022.885291"},{"key":"1829_CR14","doi-asserted-by":"crossref","unstructured":"Wang X, Xu C, Grzegorzek M, Sun H. Habitat radiomics analysis of pet\/ct imaging in high-grade serous ovarian cancer: application to Ki-67 status and progression-free survival. Front Physiol 2022, 13.","DOI":"10.3389\/fphys.2022.948767"},{"issue":"1","key":"1829_CR15","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3174\/ajnr.A7351","volume":"43","author":"SY Jeong","year":"2022","unstructured":"Jeong SY, Park JE, Kim N, Kim HS. Hypovascular cellular tumor in primary central nervous system lymphoma is associated with treatment resistance: tumor habitat analysis using physiologic MRI. Am J Neuroradiol. 2022;43(1):40\u20137.","journal-title":"Am J Neuroradiol"},{"issue":"5","key":"1829_CR16","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1007\/s00259-022-06089-w","volume":"50","author":"WP Fendler","year":"2023","unstructured":"Fendler WP, Eiber M, Beheshti M, Bomanji J, Calais J, Ceci F, Cho SY, Fanti S, Giesel FL, Goffin K, et al. PSMA PET\/CT: joint EANM procedure guideline\/snmmi procedure standard for prostate cancer imaging 2.0. Eur J Nucl Med Mol Imaging. 2023;50(5):1466\u201386.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"9","key":"1829_CR17","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.mri.2012.05.001","volume":"30","author":"A Fedorov","year":"2012","unstructured":"Fedorov A, Beichel R, Kalpathy-Cramer J, Finet J, Fillion-Robin J-C, Pujol S, Bauer C, Jennings D, Fennessy F, Sonka M, et al. 3D slicer as an image computing platform for the quantitative imaging network. Magn Reson Imaging. 2012;30(9):1323\u201341.","journal-title":"Magn Reson Imaging"},{"key":"1829_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2023\/9161763","volume":"2023","author":"S Li","year":"2023","unstructured":"Li S, Chen C, Zhu H, Lin Q, Yu Z. Risk evaluation of bone metastases and a simple tool for detecting bone metastases in prostate cancer: A Population-Based study. Comput Math Methods Med. 2023;2023:1\u201313.","journal-title":"Comput Math Methods Med"},{"issue":"1","key":"1829_CR19","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s40644-024-00670-2","volume":"24","author":"H Zhao","year":"2024","unstructured":"Zhao H, Su Y, Wang Y, Lyu Z, Xu P, Gu W, Tian L, Fu P. Using tumor habitat-derived radiomic analysis during pretreatment (18)F-FDG PET for predicting KRAS\/NRAS\/BRAF mutations in colorectal cancer. Cancer Imaging. 2024;24(1):26.","journal-title":"Cancer Imaging"},{"issue":"8","key":"1829_CR20","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1007\/s00259-023-06187-3","volume":"50","author":"S Ghezzo","year":"2023","unstructured":"Ghezzo S, Mapelli P, Bezzi C, Samanes Gajate AM, Brembilla G, Gotuzzo I, Russo T, Preza E, Cucchiara V, Ahmed N, et al. Role of [68Ga]Ga-PSMA-11 PET radiomics to predict post-surgical ISUP grade in primary prostate cancer. Eur J Nucl Med Mol Imaging. 2023;50(8):2548\u201360.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"1829_CR21","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","volume":"79","author":"N Mottet","year":"2021","unstructured":"Mottet N, van den Bergh RCN, Briers E, Van den Broeck T, Cumberbatch MG, De Santis M, Fanti S, Fossati N, Gandaglia G, Gillessen S, et al. EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate Cancer\u20142020 update. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol. 2021;79(2):243\u201362.","journal-title":"Eur Urol"},{"key":"1829_CR22","doi-asserted-by":"crossref","unstructured":"Zang S, Ai S, Yang R, Zhang P, Wu W, Zhao Z, Ni Y, Zhang Q, Sun H, Guo H et al. Development and validation of 68Ga-PSMA-11 PET\/CT-based radiomics model to detect primary prostate cancer. EJNMMI Res 2022, 12(1).","DOI":"10.1186\/s13550-022-00936-5"},{"key":"1829_CR23","doi-asserted-by":"crossref","unstructured":"Wang Z, Li Y, Zheng A, Gao J, Yuan W, Shen C, Bai L, Duan X. Evaluation of a radiomics nomogram derived from Fluoride-18 PSMA-1007 PET\/CT for risk stratification in newly diagnosed prostate cancer. Front Oncol 2022, 12.","DOI":"10.3389\/fonc.2022.1018833"},{"issue":"5","key":"1829_CR24","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1007\/s00259-021-05631-6","volume":"49","author":"Z Yi","year":"2021","unstructured":"Yi Z, Hu S, Lin X, Zou Q, Zou M, Zhang Z, Xu L, Jiang N, Zhang Y. Machine learning-based prediction of invisible intraprostatic prostate cancer lesions on 68 Ga-PSMA-11 PET\/CT in patients with primary prostate cancer. Eur J Nucl Med Mol Imaging. 2021;49(5):1523\u201334.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"1829_CR25","doi-asserted-by":"publisher","first-page":"68","DOI":"10.18383\/j.tom.2018.00037","volume":"5","author":"NA Parra","year":"2019","unstructured":"Parra NA, Lu H, Choi J, Gage K, Pow-Sang J, Gillies RJ, Balagurunathan Y. Habitats in DCE-MRI to predict clinically significant prostate cancers. Tomography. 2019;5(1):68\u201376.","journal-title":"Tomography"},{"issue":"3","key":"1829_CR26","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1080\/14737159.2023.2192351","volume":"23","author":"L Filippi","year":"2023","unstructured":"Filippi L, Urso L, Bianconi F, Palumbo B, Marzola MC, Evangelista L, Schillaci O. Radiomics and theranostics with molecular and metabolic probes in prostate cancer: toward a personalized approach. Expert Rev Mol Diagn. 2023;23(3):243\u201355.","journal-title":"Expert Rev Mol Diagn"},{"issue":"16","key":"1829_CR27","doi-asserted-by":"publisher","first-page":"8027","DOI":"10.7150\/thno.61207","volume":"11","author":"SKB Spohn","year":"2021","unstructured":"Spohn SKB, Bettermann AS, Bamberg F, Benndorf M, Mix M, Nicolay NH, Fechter T, H\u00f6lscher T, Grosu R, Chiti A, et al. Radiomics in prostate cancer imaging for a personalized treatment approach - current aspects of methodology and a systematic review on validated studies. Theranostics. 2021;11(16):8027\u201342.","journal-title":"Theranostics"},{"key":"1829_CR28","doi-asserted-by":"crossref","unstructured":"He M, Cao Y, Chi C, Yang X, Ramin R, Wang S, Yang G, Mukhtorov O, Zhang L, Kazantsev A et al. Research progress on deep learning in magnetic resonance imaging\u2013based diagnosis and treatment of prostate cancer: a review on the current status and perspectives. Front Oncol 2023, 13.","DOI":"10.3389\/fonc.2023.1189370"},{"issue":"2","key":"1829_CR29","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.eururo.2008.03.049","volume":"54","author":"MS Cohen","year":"2008","unstructured":"Cohen MS, Hanley RS, Kurteva T, Ruthazer R, Silverman ML, Sorcini A, Hamawy K, Roth RA, Tuerk I, Libertino JA. Comparing the Gleason prostate biopsy and Gleason prostatectomy grading system: the Lahey clinic medical center experience and an international Meta-Analysis. Eur Urol. 2008;54(2):371\u201381.","journal-title":"Eur Urol"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-01829-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-025-01829-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-01829-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T16:21:28Z","timestamp":1757262088000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedimaging.biomedcentral.com\/articles\/10.1186\/s12880-025-01829-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,21]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1829"],"URL":"https:\/\/doi.org\/10.1186\/s12880-025-01829-4","relation":{},"ISSN":["1471-2342"],"issn-type":[{"type":"electronic","value":"1471-2342"}],"subject":[],"published":{"date-parts":[[2025,7,21]]},"assertion":[{"value":"28 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was carried out in accordance with the Declaration of Helsinki. We confirm that all methods were carried out in accordance with relevant guide-lines and regulations. The study protocol was approved by the Ethics Review Committee of the First Affiliated Hospital of Harbin Medical University (approval no. 2020XJSS33). A clinical translational study of 18\u00a0F-PSMA-1007-PET\/CT is registered with the Chinese Clinical Trial Registry (ChiCTR2100052238). All patients who underwent 18\u00a0F-PSMA-1007-PET\/CT examinations in our institution submitted written informed consent for potential scientific use.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"293"}}